Dis-Chem Pharmacies Limited announced revenue results for the year ended 28 February 2023. For year, the Group recorded revenue growth (excluding the contribution of COVID-19 vaccines and testing) of 9.0% compared to the corresponding financial period.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.54 ZAR | +5.62% | +4.63% | +6.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.03% | 1.49B | |
-32.21% | 15.27B | |
-31.97% | 10.84B | |
-30.42% | 6.06B | |
+8.14% | 6.04B | |
-11.41% | 5.86B | |
-1.17% | 4.71B | |
+52.19% | 4.29B | |
-14.86% | 3.33B | |
-6.93% | 3.01B |
- Stock Market
- Equities
- DCP Stock
- News Dis-Chem Pharmacies Limited
- Dis-Chem Pharmacies Limited Announces Revenue Results for the Year Ended 28 February 2023